Inventor profile of:

Saskia Maria Brachmann

City:

Basel

Country:

Switzerland

Published Applications:

9

Last publication date:

2024-11-07

Top Assignees for applications by Saskia Maria Brachmann

The entities that hold a legal rights for patent applications filed by inventor Brachmann Saskia Maria:

Recent patent applications by Brachmann Saskia Maria

Saskia Maria Brachmann from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-11-07
US20240366567A1
Human necessities

PHARMACEUTICAL COMBINATIONS COMPRISING A KRAS G12C INHIBITOR AND USES THEREOF FOR THE TREATMENT OF CANCERS

#2 | 2024-09-26
US20240317721A1
Chemistry; metallurgy

PYRAZOLYL DERIVATIVES AS INHIBITORS OF THE KRAS MUTANT PROTEIN

#3 | 2024-03-14
US20240082218A1
Human necessities

PHARMACEUTICAL COMBINATIONS COMPRISING A KRAS G12C INHIBITOR AND USES OF A KRAS G12C INHIBITOR FOR THE TREATMENT OF CANCERS

#4 | 2022-05-19
US20220152026A1
Human necessities

PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND A KRASG12C INHIBITOR

#5 | 2020-01-23
US20200022967A1
Human necessities

Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members

#6 | 2018-11-15
US20180325883A1
Human necessities

Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members

#7 | 2015-09-10
US20150250778A1
Human necessities

Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members

#8 | 2013-08-15
US20130209461A1
Human necessities

Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members

#9 | 2010-04-29
US20100105696A1
Human necessities

Imidazoquinolines as dual lipid kinase and mTOR inhibitors

InventorID:

388492 ⎘